Andrea Altieri Selected Research

Andrea Altieri Research Topics

Disease

10	Neoplasms (Cancer) 12/2022 - 02/2002
4	Body Weight (Weight, Body) 04/2019 - 05/2017
3	Breast Neoplasms (Breast Cancer) 05/2008 - 01/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 03/2010 - 06/2008
2	Neoplasm Metastasis (Metastasis) 05/2008 - 11/2003
2	Prostatic Neoplasms (Prostate Cancer) 12/2007 - 04/2005
1	COVID-19 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	autosomal dominant Spastic paraplegia 6 12/2022
1	Vomiting 08/2018
1	Infections 01/2017
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2010
1	Inflammation (Inflammations) 06/2008
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2005
1	Nevus (Nevi) 10/2005
1	Lentigo (Lentiginosis) 10/2005
1	Sunburn 10/2005
1	Choriocarcinoma 11/2003

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 05/2008
2	EnzymesIBA 07/2022 - 04/2008
2	ORALIT (ORS)IBA 10/2005 - 04/2005
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Indicators and Reagents (Reagents)IBA 12/2022
1	CarbonIBA 12/2022
1	HydrogenIBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	Cadherins (E-Cadherin)IBA 12/2022
1	Fibronectins (Fibronectin)IBA 12/2022
1	MethyltransferasesIBA 12/2022
1	Cyclin-Dependent Kinase 2IBA 12/2022
1	NAD (NADH)IBA 07/2022
1	PrionsIBA 11/2020
1	Cyanides (Isocyanides)IBA 04/2019
1	cyanogenic glycosidesIBA 04/2019
1	diacetoxyscirpenolIBA 08/2018
1	amsonic acid (DAS)IBA 08/2018
1	Antineoplastic Agents (Antineoplastics)IBA 08/2018
1	Sodium Glutamate (Accent)IBA 07/2017
1	sorbitan monolaurateIBA 05/2017
1	NBD-11021IBA 01/2017
1	Prion ProteinsIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	N 30IBA 08/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2010
1	Growth InhibitorsIBA 03/2010
1	Transforming Growth Factor-beta Type I ReceptorIBA 03/2010
1	CarcinogensIBA 03/2010
1	FurinIBA 03/2010
1	InterleukinsIBA 06/2008
1	Plasminogen Activator Inhibitor 1IBA 05/2008
1	PlasminogenIBA 05/2008
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2008
1	Oxidoreductases (Dehydrogenase)IBA 04/2008
1	AldehydesIBA 04/2008
1	Coffee FDA Link 12/2007
1	Matrix Metalloproteinases (MMPs)IBA 05/2007
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2007
1	Estrogen ReceptorsIBA 01/2007
1	Phosphotransferases (Kinase)IBA 01/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007
1	Environmental CarcinogensIBA 11/2005
1	SolventsIBA 11/2005
1	Oral ContraceptivesIBA 11/2003
1	Blood Group Antigens (Blood Groups)IBA 11/2003
1	FatsIBA 02/2002

Therapy/Procedure

1	Intravenous Administration 08/2018
1	Therapeutics 01/2017
1	Drug Therapy (Chemotherapy) 11/2003